BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15079-15086 [PMID: 25386056 DOI: 10.3748/wjg.v20.i41.15079]
URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15079.htm
Number Citing Articles
1
Chengjun Wei, Hongxia Zhang, Chenghong Wei, Youyan Mao. Correlation of the expression of miR-146a in peripheral blood mononuclear cells of patients with ankylosing spondylitis and inflammatory factorsExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5155
2
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigmsWorld Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
3
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Esther Guiu-Jurado, Andreu Martí, Salomé Martínez, Fàtima Sabench, Mercé Hernández, Carmen Aguilar, Joan Sirvent, Daniel Del Castillo, Cristóbal Richart. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2016; 17(10): 1620 doi: 10.3390/ijms17101620
4
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASHBiomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
5
Hyun Yi Kook, So‐Hee Jin, Pu‐Reum Park, Seung‐Jin Lee, Hong‐Joon Shin, Tae‐Jong Kim. Serum miR‐214 as a novel biomarker for ankylosing spondylitisInternational Journal of Rheumatic Diseases 2019; 22(7): 1196 doi: 10.1111/1756-185X.13475
6
Carla Bizzarri, Rita M. Pinto, Sara Ciccone, Letizia P. Brescia, Franco Locatelli, Marco Cappa. Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantationPediatric Blood & Cancer 2015; 62(9): 1650 doi: 10.1002/pbc.25603
7
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive DiagnosisInternational Journal of Molecular Sciences 2018; 19(12): 3966 doi: 10.3390/ijms19123966
8
Anurag Mishra, Adiba Nizam, Rajdeep Singh. Gallbladder Cancer2023; : 177 doi: 10.1007/978-981-19-6442-8_11
9
Rodica Talmaci. miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventionsDietetician.ro 2023; 3(3): 18 doi: 10.26416/Diet.3.3.2023.8754
10
Henry Wade, Qiaozhu Su. Comprehensive Foodomics2021; : 398 doi: 10.1016/B978-0-08-100596-5.22723-6
11
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver diseaseMolecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
12
Marica Meroni, Miriam Longo, Veronica Erconi, Luca Valenti, Stefano Gatti, Anna Ludovica Fracanzani, Paola Dongiovanni. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin ResistanceNutrients 2019; 11(11): 2597 doi: 10.3390/nu11112597
13
Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri, Sneha S. Pillai. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease ProgressionBiomedicines 2023; 11(6): 1597 doi: 10.3390/biomedicines11061597
14
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the diseaseAnnals of Hepatology 2021; 21: 100212 doi: 10.1016/j.aohep.2020.04.012
15
Fengqiong Liu, Qing Chen, Fa Chen, Jing Wang, Ruijie Gong, Baochang He. The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(10): 1449 doi: 10.1016/j.bbalip.2019.07.003
16
Azahara I. Rupérez, Augusto Anguita-Ruiz. Obesity2018; : 17 doi: 10.1016/B978-0-12-812504-5.00002-7
17
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseasesNutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
18
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCCBiomedicines 2021; 9(11): 1524 doi: 10.3390/biomedicines9111524
19
Vishal Chandra, Jong Joo Kim, Balraj Mittal, Rajani Rai. MicroRNA aberrations: An emerging field for gallbladder cancer managementWorld Journal of Gastroenterology 2016; 22(5): 1787-1799 doi: 10.3748/wjg.v22.i5.1787
20
Fernanda Torres Quitete, Ananda Vitória Silva Teixeira, Thamara Cherem Peixoto, Bruna Cadete Martins, Geórgia Correa Atella, Angela de Castro Resende, Daniela de Barros Mucci, Fabiane Martins, Julio Beltrame Daleprane, Partha Mukhopadhyay. Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 micePLOS ONE 2024; 19(8): e0308334 doi: 10.1371/journal.pone.0308334
21
Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular MechanismsCurrent Molecular Pharmacology 2022; 15(6): 846 doi: 10.2174/1874467215666211217120448
22
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae, Soheyla Khakdan. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic ratsArchives of Physiology and Biochemistry 2020; 126(3): 242 doi: 10.1080/13813455.2018.1510968
23
Junjie Xiao, Dongchao Lv, Yingying Zhao, Xiaoyu Chen, Meiyi Song, Jingqi Liu, Yihua Bei, Fei Wang, Wenzhuo Yang, Changqing Yang. miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21Journal of Cellular and Molecular Medicine 2016; 20(8): 1603 doi: 10.1111/jcmm.12848
24
Li Su, Mingmei Liu. Correlation analysis on the expression levels of microRNA‑23a and microRNA‑23b and the incidence and prognosis of ovarian cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8669
25
Anıl Delik, Sadık Dinçer, Hikmet Akkız. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesisMeta Gene 2020; 24: 100647 doi: 10.1016/j.mgene.2020.100647
26
Mario Bartiromo, Michele Nardolillo, Serena Ferrara, Giuseppina Russo, Emanuele Miraglia Del Giudice, Anna Di Sessa. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?Expert Review of Gastroenterology & Hepatology 2023; 17(8): 817 doi: 10.1080/17474124.2023.2242245
27
Mona A Hegazy, Ibrahim Abd ALgwad, Soheir Abuel Fadl, Mohamed Sayed Hassan, Laila Ahmed Rashed, Maha A Hussein. Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD SeverityDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 2247 doi: 10.2147/DMSO.S291595
28
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect BinomiumInternational Journal of Molecular Sciences 2020; 21(8): 2986 doi: 10.3390/ijms21082986
29
Fatiha Nassir. NAFLD: Mechanisms, Treatments, and BiomarkersBiomolecules 2022; 12(6): 824 doi: 10.3390/biom12060824
30
Taruna Ahrodia, Bharti Kandiyal, Bhabatosh Das. Epigenetics in Health and Disease - Part BProgress in Molecular Biology and Translational Science 2023; 198: 93 doi: 10.1016/bs.pmbts.2023.03.018
31
Dafei Xie, Peiwen Yuan, Dong Wang, Hua Jin, Hui Chen. Expression and prognostic significance of miR-375 and miR-221 in liver cancerOncology Letters 2017; 14(2): 2305 doi: 10.3892/ol.2017.6423
32
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(8): 733 doi: 10.1080/17474124.2020.1780915
33
Bo Zhang, Haijun Li, Dongwei Li, Hongzhi Sun, Mingqiang Li, Huawen Hu. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5pGene 2019; 700: 139 doi: 10.1016/j.gene.2019.02.096
34
Hualin Wang, Yang Shao, Fahu Yuan, Han Feng, Na Li, Hongyu Zhang, Chaodong Wu, Zhiguo Liu. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat ModelBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/2503847
35
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
36
Zhila Bahramirad, Mohammad Raman Moloudi, Mohammad Moradzad, Alina Abdollahi, Zakaria Vahabzadeh. Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell ModelBiochemical Genetics 2024;  doi: 10.1007/s10528-024-10754-0
37
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical ImpactProcesses 2021; 9(1): 135 doi: 10.3390/pr9010135
38
Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21Journal of Cellular and Molecular Medicine 2016; 20(2): 204 doi: 10.1111/jcmm.12733
39
Matthew Nayor, Svati H. Shah, Venkatesh Murthy, Ravi V. Shah. Molecular Aspects of Lifestyle and Environmental Effects in Patients With DiabetesJournal of the American College of Cardiology 2021; 78(5): 481 doi: 10.1016/j.jacc.2021.02.070
40
Jinkyung Cho, Jinhwan Yoon, Inho Park, Hyunsik Kang. Effect of Training Intensity on Hepatic Steatosis and Expression of miRNAs and Target Genes in a High-fat Diet-induced MiceExercise Science 2018; 27(1): 32 doi: 10.15857/ksep.2018.27.1.32
41
Guan Wang, Haibo Zou, Chunyou Lai, Xiaolun Huang, Yutong Yao, Guangming Xiang. Repression of MicroRNA-124-3p Alleviates High-Fat Diet–Induced Hepatosteatosis by Targeting Pref-1Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.589994
42
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2015; 16(3): 5161 doi: 10.3390/ijms16035161
43
György Baffy. MicroRNAs in Nonalcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2015; 4(12): 1977 doi: 10.3390/jcm4121953
44
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver DiseaseGastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
45
Prajakta C. Shimpi, Vijay R. More, Maneesha Paranjpe, Ajay C. Donepudi, Jaclyn M. Goodrich, Dana C. Dolinoy, Beverly Rubin, Angela L. Slitt. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver DiseaseEnvironmental Health Perspectives 2017; 125(8) doi: 10.1289/EHP664
46
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver diseaseFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1046497
47
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)Metabolism 2016; 65(8): 1038 doi: 10.1016/j.metabol.2015.12.012
48
Jun-Ke Long, Wen Dai, Ya-Wen Zheng, Shui-Ping Zhao. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver diseaseMolecular Medicine 2019; 25(1) doi: 10.1186/s10020-019-0085-2
49
Fengqiong Liu, Ruijie Gong, Xiaofei Lv, Huangyuan Li. The expression profiling and ontology analysis of non-coding RNAs in dexamethasone induced steatosis in hepatoma cellGene 2018; 650: 19 doi: 10.1016/j.gene.2018.01.089
50
Yong-Hong Zhang, Heng-Li Xie, Yu-Wei Yang, Jie Wen, Ran-Ran Liu, Gui-Ping Zhao, Xiao-Dong Tan, Zhen Liu, Yi Zheng, Jia-Bao Zhang. miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ)Poultry Science 2023; 102(1): 102218 doi: 10.1016/j.psj.2022.102218
51
Lide Arenaza, María Medrano, María Amasene, Beatriz Rodríguez-Vigil, Ignacio Díez, Manuel Graña, Ignacio Tobalina, Edurne Maiz, Edurne Arteche, Eider Larrarte, Inge Huybrechts, Catherine L. Davis, Jonatan R. Ruiz, Francisco B. Ortega, Javier Margareto, Idoia Labayen. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trialTrials 2017; 18(1) doi: 10.1186/s13063-017-2117-y